Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy-Reference-Cited by-同舟云学术

Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy

Published:2021-12-03 Issue:2 Volume:31 Page:352-361
ISSN:1055-9965
Container-title:Cancer Epidemiology Biomarkers & Prevention
language:en
Short-container-title:Cancer Epidemiol Biomarkers Prev

Author:

Park Hanla A.^ORCID,Seibold Petra,Edelmann Dominic,Benner Axel^ORCID,Canzian Federico^ORCID,Alwers Elizabeth,Jansen Lina^ORCID,Schneider Martin,Hoffmeister Michael^ORCID,Brenner Hermann^ORCID,Chang-Claude Jenny^ORCID

Funder

German Research Council

German Federal Ministry of Education and Research

NCI

NIH

US Department of Health and Human Services

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Loss-of-function/gain-of-function polymorphisms of the ATP sensitive P2X7R influence sepsis, septic shock, pneumonia, and survival outcomes;Frontiers in Immunology;2024-06-20

2. Genetic Polymorphisms of P2RX7 but Not of ADORA2A Are Associated with the Severity of SARS-CoV-2 Infection;International Journal of Molecular Sciences;2024-06-02

3. A perspective on tumor radiation resistance following high-LET radiation treatment;Journal of Cancer Research and Clinical Oncology;2024-05-02

4. Flipping the script: Advances in understanding how and why P4-ATPases flip lipid across membranes;Biochimica et Biophysica Acta (BBA) - Molecular Cell Research;2024-04

5. Oxaliplatin and its derivatives – An overview;Coordination Chemistry Reviews;2023-12